Stada

Bad Vilbel, Germany Founded: 1895 • Age: 131 yrs Listed Acquired By CapVest
Provider of generics and biosimilars

About Stada

Stada is a Healthcare company based in Bad Vilbel (Germany) founded in 1895, and was acquired by CapVest in September 2025. Provider of generics and biosimilars. The company has 30 employees. Stada has completed 9 acquisitions, including Aqualor, Clare Fischer and Hemofarm. Its chief executive, as recorded, is Claudio Albrecht. Its website stada.com draws about 80 thousand monthly visits. Its Indian entity Stada Pharma Services India Private Limited reported revenue of β‚Ή22.45 Cr. Its focus areas include Diversified Pharmaceuticals.

Company details

Stada was founded in 1895 and is based in Bad Vilbel, Germany. Operations are focused on the pharmaceutical sector, where generics and biosimilars are developed and distributed. An extensive portfolio is maintained, encompassing treatments for pain, cholesterol management, stomach ulcers, hypertension, central nervous system disorders, inflammatory conditions, and other areas. Manufacturing and distribution facilities are operated in Germany, the UK, Russia, China, Argentina, and various additional countries.

Key Metrics
  • Indian entity revenue
    ₹22.45 Cr

    FY 2025 · +38% YoY

  • Indian entity net profit
    ₹1.51 Cr

    FY 2025 · 7% margin

  • Indian entity EBITDA
    ₹2.04 Cr

    FY 2025 · 9% margin

  • Investors
    HSBC

    & 10 more

  • Employee Count
    30
  • Investments & Acquisitions
    Aqualor

    & 8 more

  • Acquired by
    CapVest

    & 1 more

    (Sep 2025)

Apps and channels of Stada

its YouTube channel STADA has 8.01K subscribers and 30 videos.

STADA
YouTube 8.01K subscribers 30 videos Sports
Open channel

Videos from Stada

The most watched videos on Stada's YouTube channel, STADA (8.01K subscribers). Click a video to play it here.

STADA Grippostad Q4 24 YouTube PreRoll Dog
14.5M views
STADA Grippostad Q4 24 YouTube PreRoll
8.6M views
Daosin | Q2 2025
319.5K views
Antistax | TV-Clip | Q2 2024
1.9K views

More on STADA.

Funding Insights of Stada

  • Total Rounds 5
  • Investors Count 8

All 5 funding rounds of Stada with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Jul 2017Post-IPO––
Jun 2017Post-IPO––
Apr 2015$323.03MDebt – Conventional––
May 2013$451.6MDebt – Conventional––
Oct 2003Post-IPO––
–
Valuation history

11 investors in total: 11 institutional.

Investors in Stada

Stada has secured backing from 11 investors, including institutional and venture fund investors. Prominent investors backing the company include HSBC, Deutsche Bank and UniCredit.

All
Venture Fund
Institutional
InvestorDescriptionFounded YearDomainLocation
Private investment firm managing assets and expanding into equity, credit, and real estate services.
1984baincapitalprivateequity.comLondon, United Kingdom
CapVest is recognized as a leading private equity investor.
1999capvest.comLondon, United Kingdom
Private equity investments and portfolio management services are provided by Cinven across various sectors.
cinven.com
Pension fund assets are managed for sustainable long-term growth.
1997cppinvestments.comToronto, Canada
Multiple sectors are invested in by the hedge fund.
1977elliottmgmt.comNew York, United States
Commercial banking services are offered to corporate and retail clients.
1870commerzbank.comFrankfurt, Germany
bvr.de
Universal banking and financial advisory services are provided globally.
1865hsbc.comLondon, United Kingdom
Commercial bank
1998unicreditgroup.euMilan, Italy
Diversified banking and financial services are provided globally.
1870db.comFrankfurt Am Main, Germany
Premium access

Investor details for Stada

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Board of directors of Stada Pharma Services India Private Limited (Stada)

Stada Pharma Services India Private Limited is the primary company behind Stada. The board of Stada Pharma Services India Private Limited currently have 3 directors; the longest-serving is Pradeep Kumar Mohakhud, appointed in 2014. 8 earlier directors have ceased.

DirectorDesignationAppointedTenureEntity
Pradeep Kumar Mohakhud
DIN 06965663
Director12 Aug 201412 yrs 2 moStada Pharma Services India Private Limited
Dirk Welsch
DIN 08403629
Director30 Jan 20197 yrs 9 moStada Pharma Services India Private Limited
Tim Adolphs
DIN 09624500
Director08 Jun 20224 yrs 4 moStada Pharma Services India Private Limited

People of Stada

383 people are tracked at Stada (172 in leadership, 9 in board & advisors, 202 in team); the tracked headcount is 30.

NameRoleGroup
Claudio Albrecht
CEOLeadership
Simone Berger
Chief People OfficerLeadership
Annette Chahboune
Head Of Coe Culture & People DevelopmentLeadership
Yann Brun
Executive Vice PresidentLeadership
Frank Staud
Executive Vice President Corporate Communications, Branding & SponsoringLeadership
Bertrand Jacob
Associate Director FinanceLeadership
Iuliana Kusai
Ms&t Head At StadaLeadership
Cezara Popa
Site HeadLeadership
Boris Doebler
CFO Stada GroupLeadership
Paul Davies
UK Director Of EngineeringLeadership
Miguel Navarrete
Hospital & Biosimilars Commercial DirectorLeadership
Florian Kropf
Head Of Marketing Consumer Health GermanyLeadership
Christin Berthold
Global Marketing Director CHCLeadership
Anja Schneider
Director Insights & AnalyticsLeadership
Christos Gallis
Executive Vice PresidentLeadership
Brigitte Michaud
Head Of Business TransformationLeadership
Ann-Sophie Vondung
Director Global Quality Assurance & Supply ChainLeadership
Monica Aragoneses Palomo
Global Product Development And ESO Quality DirectorLeadership
Stephen King
Global Director Of Quality For Operations And CommercialLeadership
Janina Padilla
Executive Assistant To Chief Technical OfficerLeadership

363 more people are available in the full profile.

Premium access

Complete people profiles for Stada

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Financials of Stada

Figures of Stada Pharma Services India Private Limited, the primary company behind Stada, for FY 2025. Revenue was ₹22.45 Cr (+38% year on year). Net profit was ₹1.51 Cr (7% margin). EBITDA was ₹2.04 Cr (9% margin). Revenue has grown at a compounded annual rate of +45% over three years and +30% over five years.

  • ₹22.45 CrRevenue · FY 2025 · +38% YoY
  • ₹1.51 CrNet profit · 7% margin
  • ₹2.04 CrEBITDA · 9% margin
  • ₹1.00 CrPaid-up capital
  • 30Employees (provident fund records)
  • +45%Revenue CAGR, 3 years
  • +30%Revenue CAGR, 5 years

Balance sheet, profit and loss, cash flow and ratios of Stada Pharma Services India Private Limited are on its company page.

Premium access

Detailed financial statements for Stada

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Stada

Stada has strategically engaged in corporate development activities, having acquired 9 companies. Notable acquisitions include Aqualor, Clare Fischer and Hemofarm.

Acquisitions
Company NameDescriptionDomainLocationFoundedAcquiredAmount
Hair care products are offered by an internet-first brand.
phyto.comNassau, United States1966Aug 2024β€’β€’β€’β€’
A range of OTC products and dietary supplements is manufactured.
biopharma.com.uaKiev, Ukraine1896Dec 2019β€’β€’β€’β€’
Drugs and medical supplies are manufactured by PYMEPHARCO.
pymepharco.comHo Chi Minh, Vietnam1989Dec 2018β€’β€’β€’β€’
Contract development and manufacturing services for pharmaceutical APIs are provided.
riemser.comGreifswald, Germany2000Mar 2018β€’β€’β€’β€’
Nutrition supplements for daily needs
naturesaid.co.ukPreston, United Kingdom1981Nov 2016β€’β€’β€’β€’
Music recording and print services are provided to clients.
clarefischer.comStudio, United States1999Jun 2014β€’β€’β€’β€’
Manufacturer of nasal drugs
aqualor.ruRussia2007Oct 2013$180M
Dermatology-focused biopharma products are developed by Spirig Pharma in Switzerland.
spirig.chLausanne, Switzerland1996Jan 2012$105.81M
Hemofarm is a Serbian pharmaceutical company and a member of the STADA Group, known for its manufacturing processes in the pharmaceutical industry.
hemofarm.comVrsac, Serbia1960Sep 2006β€’β€’β€’β€’
Premium access

Complete acquisition details for Stada

Acquired stakes, deal sources and the complete acquisition history require an active premium plan.

  • Acquired stakes
  • Deal sources
  • Complete history
  • Exports

Verified entity values are shown only after access is granted.

Timeline of Stada

15 dated milestones of Stada across 130 years, from founding to its latest funding, stage changes and deals.

  1. Founded Stada is founded.
  2. IPO Lists on the stock exchange (IPO).
  3. Funding First funding round.
  4. Acquisition Acquires Hemofarm.
  5. Acquisition Acquires Spirig Pharma.
  6. Acquisition Acquires Aqualor.
  7. Acquisition Acquires Clare Fischer.
  8. Acquisition Acquires NaturesAid.
  9. Exit Acquired by Bain Capital Private Equity.
  10. Funding Latest funding round, Post-IPO,.
  11. Acquisition Acquires RIEMSER Pharma.
  12. Acquisition Acquires PYMEPHARCO.
  13. Acquisition Acquires biopharma.
  14. Acquisition Acquires PHYTO.
  15. Exit Acquired by CapVest.

Web traffic of Stada

The website of Stada (stada.com) receives about 79.7K visits a month and ranks #482,860 among all websites worldwide, #469 in Biotechnology and Pharmaceuticals.

  • Monthly visits
    79.7K

    ▲ 16.1% vs previous month

  • Unique visitors
    28.7K

    per month

  • Global rank
    #482,860

    among all websites

  • Category rank
    #469

    Health · Biotechnology and Pharmaceuticals

Similar websites

Websites whose visitors overlap most with Stada. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
bio-thera.com
100%
1.4K#6,055,597View details
drugdiscoverytrends.com
drugdiscoverytrends.com
100%
#491,427–
clinicaltrialsregister.eu
clinicaltrialsregister.eu
100%
#523,655–
helserespons.no
63%
#751,870View details
werkenbijumcutrecht.nl
werkenbijumcutrecht.nl
62%
#542,884–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
Premium access

All 21 similar websites and full traffic analytics for Stada

The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.

  • 21 similar websites
  • Audience overlap
  • Engagement analytics
  • Traffic by brand

Verified entity values are shown only after access is granted.

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Stada

Premium access

Complete news archive for Stada

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Stada

Stada was founded in 1895 and raised its 1st funding round 108 years after it was founded.

Stada is headquartered in Bad Vilbel, Germany. It is registered at Bad Vilbel, Hesse, Germany.

Claudio Albrecht is the CEO of Stada, as recorded in our data.

Stada has 30 employees.

The primary company behind Stada, Stada Pharma Services India Private Limited, reported revenue of β‚Ή22.45 Cr for FY 2025, up 38% year on year.

Stada was founded in 1895 and is based in Bad Vilbel, Germany. Operations are focused on the pharmaceutical sector, where generics and biosimilars are developed and distributed. An extensive portfolio is maintained, encompassing treatments for pain, cholesterol management, stomach ulcers, hypertension, central nervous system disorders, inflammatory conditions, and other areas. Manufacturing and distribution facilities are operated in Germany, the UK, Russia, China, Argentina, and various additional countries.

Stada has made 9 acquisitions, including Aqualor, Clare Fischer, and Hemofarm.

Stada has 11 investors. Key investors include HSBC, Deutsche Bank, UniCredit, Elliott Management, and Commerzbank.

Stada operates through Stada Pharma Services India Private Limited.

Yes. Stada was acquired by Bain Capital Private Equity in April 2017.

The legal entities of Stada currently have 3 directors, including Tim Adolphs, Pradeep Kumar Mohakhud, Dirk Welsch.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available